- Home
- CPRX vs HURN Comparison
CPRX vs HURN Comparison
Compare CPRX & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- HURN
- Stock Information
- Founded
- CPRX 2002
- HURN 2002
- Country
- CPRX United States
- HURN United States
- Employees
- CPRX N/A
- HURN N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- HURN Professional Services
- Sector
- CPRX Health Care
- HURN Consumer Discretionary
- Exchange
- CPRX Nasdaq
- HURN Nasdaq
- Market Cap
- CPRX 2.9B
- HURN 2.6B
- IPO Year
- CPRX 2006
- HURN 2004
- Fundamental
- Price
- CPRX $23.37
- HURN $150.46
- Analyst Decision
- CPRX Strong Buy
- HURN Strong Buy
- Analyst Count
- CPRX 7
- HURN 5
- Target Price
- CPRX $32.29
- HURN $158.60
- AVG Volume (30 Days)
- CPRX 975.9K
- HURN 240.0K
- Earning Date
- CPRX 05-07-2025
- HURN 04-29-2025
- Dividend Yield
- CPRX N/A
- HURN N/A
- EPS Growth
- CPRX 178.13
- HURN 92.74
- EPS
- CPRX 1.57
- HURN 6.67
- Revenue
- CPRX $534,645,999.00
- HURN $1,525,814,000.00
- Revenue This Year
- CPRX $15.59
- HURN $11.10
- Revenue Next Year
- CPRX $8.90
- HURN $6.72
- P/E Ratio
- CPRX $14.90
- HURN $22.70
- Revenue Growth
- CPRX 29.97
- HURN 8.98
- 52 Week Low
- CPRX $14.47
- HURN $84.87
- 52 Week High
- CPRX $26.16
- HURN $153.85
- Technical
- Relative Strength Index (RSI)
- CPRX 50.33
- HURN 63.36
- Support Level
- CPRX $20.80
- HURN $122.32
- Resistance Level
- CPRX $25.01
- HURN $154.83
- Average True Range (ATR)
- CPRX 0.83
- HURN 4.98
- MACD
- CPRX -0.06
- HURN 1.67
- Stochastic Oscillator
- CPRX 61.05
- HURN 86.56
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.